What Happens If Prior Authorization Is Denied 2026: 5-Step Escalation Guide

Why Most Practices Miss the Fastest Fix After a PA Denial

When a prior authorization is denied, the most valuable intervention isn't the formal appeal — it's the peer-to-peer review. P2P connects your ordering physician directly to the insurer's medical director by phone, and published research shows it overturns more than 50% of denials, with rates approaching 70% in imaging and specialty procedures.

The problem: the American Medical Association's 2024 Prior Authorization Physician Survey documents widespread underutilization of peer-to-peer review — most billing teams skip straight to the formal written appeal, which is slower, requires more documentation, and closes the P2P window at some payers once the formal process starts.

This guide covers the correct response sequence — P2P first, then internal reconsideration, then formal appeal, then external review, then ALJ — with the payer-specific windows and 2026 CMS timelines that determine whether each option is still available to you.

The 5-Step Prior Authorization Denial Response Sequence

The five interventions below run from highest-overturn to last-resort. Steps 1 and 2 can often run in parallel; steps 3 through 5 are sequential escalation levels that each require the prior step to be exhausted first.

Step 1: Request Peer-to-Peer Review (Days 1–14 by Payer)

Peer-to-peer review is the fastest and highest-yield path to reversal after a PA denial. Your ordering physician presents the clinical rationale directly to the insurer's medical director in a 5–10 minute phone call — no formal appeal letter, no submission portal, no 30-day wait.

Published research across high-volume specialty practices shows P2P review overturns more than 50% of PA denials. In imaging and oncology, the rate approaches 70% when the ordering physician conducts the call rather than delegating to office staff.

How to request it:

• Call the member services or provider services number on the denial letter and ask specifically for "peer-to-peer review scheduling"
• At most payers, only the ordering or treating physician can initiate the request — billing managers alone cannot
• Have the denial reference number, patient member ID, CPT code, and a one-paragraph clinical rationale summary ready when you call
• Request the earliest available scheduling slot — most payers book within 24–72 hours

The tight window: Each payer sets its own P2P request deadline. Cigna's EviCore gives 7 calendar days; UHC gives 14 days; Aetna gives 30 days. Miss the window and this option is permanently closed. See the payer-specific deadline table in the next section.

Step 2: Internal Reconsideration

Several major payers offer an informal reconsideration step between P2P review and Level 1 formal appeal. This is a resubmission of the original authorization request with new supporting documentation, resolved under the initial-authorization timeline rather than the longer formal appeal clock.

When it applies: Aetna, UHC, and most Medicare Advantage plans allow reconsideration when genuinely new clinical information is available that was not included in the original PA request. Some BCBS affiliates — particularly Anthem Blue Cross — also offer this step.

Use it when:

• P2P review did not result in reversal
• You have new lab results, specialist consultation notes, or recently updated clinical guidelines to add
• The denial cited missing information rather than a clinical policy judgment

What it is not: Reconsideration is not the same as a Level 1 formal appeal. It uses faster timelines — 24 to 72 hours at plans that offer it — and does not consume your formal appeal rights. If reconsideration also fails, the Level 1 formal appeal deadline is still measured from the original denial date.

Step 3: Level 1 Formal Internal Appeal

The Level 1 formal written appeal is the first mandatory step in the full appeal ladder and is required before external review becomes available. It is slower than P2P and reconsideration, but it carries a high overall success rate when built on complete documentation that directly addresses the payer's clinical coverage criteria.

What to include in the submission:

• Physician-signed letter of medical necessity citing the payer's specific coverage policy by number
• Medical records covering at least 6 months of relevant treatment history
• Documentation of failed conservative or alternative treatments with specific dates and outcomes
• Two to three peer-reviewed journal abstracts supporting clinical necessity
• Completed payer appeal form (provided with the denial letter)

Filing deadline by payer:

New for 2026 under CMS-0057-F: For Medicare Advantage, Medicaid, and ACA marketplace plans, payers must now issue standard prior authorization decisions within 7 calendar days and expedited decisions within 72 hours. If the payer misses this timeline during appeal review, you can treat it as a deemed decision and move directly to external review. For insurer-specific appeal templates and submission address tables, see the complete prior authorization denial appeal guide for providers 2026.

Step 4: External Independent Review (IRO)

External review is the first escalation step outside the insurer's control. If your Level 1 formal appeal is denied, federal law requires the payer to give you access to free, independent review by board-certified physicians who have no affiliation with the insurer. The external reviewer's decision is legally binding on the payer.

Overturn rate: Approximately 40% of external reviews overturn the insurer's denial, based on HHS and state insurance department reporting data.

Who can access it:

• Fully insured commercial plans under ACA: required
• Self-funded ERISA employer plans: voluntary but widely offered
• Medicare Advantage: required by CMS (called Independent Review Entity, or IRE — conducted by Maximus Federal Services)
• Medicaid managed care: EQRO review required under federal Medicaid regulations

How to request: Instructions for requesting external review must be included in your Level 1 denial letter. The deadline to request is typically 4 months from the denial date. Standard decisions are issued within 60 days; expedited within 72 hours.

For a full walkthrough of the IRO request process by state and plan type, see the independent review organization appeal guide 2026.

Step 5: ALJ Hearing / Grievance (Medicare Advantage and Medicaid)

The Administrative Law Judge hearing is available primarily for Medicare Advantage and Medicaid managed care denials, where federal regulations establish a multi-level appeal ladder that extends beyond the IRO.

Medicare Advantage 5-level appeal ladder:

1. Level 1: Internal appeal to the MA plan (30-day standard, 72-hour expedited)
2. Level 2: IRE review by Maximus Federal Services (60-day standard, 72-hour expedited)
3. Level 3: ALJ hearing (requires the 2026 CMS minimum controversy threshold; request within 60 days of IRE decision)
4. Level 4: Medicare Appeals Council review
5. Level 5: Federal district court

Medicaid managed care: State fair hearing rights apply after exhausting plan-level internal appeals. Federal Medicaid regulations require a state administrative hearing opportunity for all coverage denials. The process varies by state but gives you the right to present oral testimony and introduce evidence that was not available during the plan-level appeal.

When ALJ is worth pursuing: ALJ hearings are slower and more formal than IRO review, but oral testimony and the ability to introduce new clinical evidence can recover denials that written-only appeals cannot reach. For Medicare Advantage specifically, the ALJ level has historically shown higher overturn rates for clinical necessity cases than IRE review alone.

Peer-to-Peer Review Windows by Payer: Don't Miss the Deadline

The P2P request deadline is the most frequently missed timeline in PA denial management. It is not printed prominently on denial letters — most practices discover it only after missing it. The table below shows current windows by payer:

The EviCore 7-day window is the most commonly missed. EviCore manages PA for imaging, musculoskeletal procedures, cardiology studies, and radiation oncology on behalf of Cigna and several BCBS affiliates — and its window is half that of Cigna direct. If the denial letter header shows "EviCore Healthcare" rather than "Cigna," the 7-day clock began when you received the denial. For a detailed EviCore-specific appeal walkthrough, see the Cigna EviCore appeal guide 2026.

What CMS-0057-F Changed in 2026

CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) took effect January 1, 2026, for Medicare Advantage organizations, Medicaid managed care plans, and ACA marketplace QHPs. These changes affect the timeline and transparency of PA decisions and appeals:

New initial PA decision timelines (enforcement strengthened):

• Standard (non-urgent) PA requests: must be decided within 7 calendar days
• Urgent/expedited PA requests: must be decided within 72 hours

The 7-day standard timeline replaces the 14-day window that most MA plans previously used. For practices that have experienced long waits on MA PA requests, the 7-day requirement creates grounds for a deemed-denial escalation if not met.

Mandatory denial specificity: Payers must now provide a specific clinical reason for every PA denial, not just a generic "medical necessity not established" code. A specific reason lets you target your appeal — and your P2P talking points — directly at the cited deficiency rather than building a general clinical case.

Public reporting requirements: Starting in 2026, covered payers must publicly report prior authorization approval rates, denial rates, average decision timelines, and appeal overturn rates. This transparency data creates a factual baseline for arguing that a payer's denial rate for your procedure type is an outlier — a useful framing at the Level 1 appeal and ALJ stages.

What CMS-0057-F does NOT change: The rule applies to MA, Medicaid, and marketplace plans — not to commercial self-funded ERISA plans. ERISA self-funded plans are regulated by the Department of Labor and follow the plan document's appeal procedures rather than CMS timelines. If you are unsure whether a plan is ERISA self-funded or fully insured, check the plan documents: if the plan sponsor is an employer, it is likely ERISA self-funded.

For the Medicare-specific PA workflow changes, including the CMS WISeR pilot affecting Original Medicare in six states, see the CMS WISeR model guide for providers 2026.

Escalation Rights by Plan Type

The appeal ladder available to a practice depends entirely on the plan type. This distinction determines which external review process applies — and whether ALJ hearings are an option.

The ERISA distinction is critical for billing teams at practices with a high volume of employer-sponsored patients. For self-funded ERISA plans, state external review laws generally do not apply — the appeal process is governed by the plan document and federal DOL regulations. External review is voluntary under ERISA, not mandatory, though the ACA requires self-funded non-grandfathered plans to have voluntary external review procedures in place.

To determine if a plan is ERISA self-funded: if the plan sponsor listed in the plan documents is an employer rather than an insurance company, the plan is almost certainly self-funded. HR departments at the employer can confirm. This distinction affects whether state-mandated appeal timelines or federal ERISA timelines govern your case.

How Muni Appeals Manages the 5-Step Sequence

Running the 5-step response correctly requires tracking five parallel deadlines — some as short as 7 days — across multiple payers, each using different portals and clinical coverage criteria.

Muni Appeals identifies the payer-specific P2P request window at denial receipt, queues the physician notification for same-day scheduling, and tracks the formal appeal deadline separately on a per-case basis. If P2P fails, the Level 1 documentation package is compiled against the payer's cited policy criteria — not a generic clinical narrative. The result is that every denial moves through the full sequence rather than only the cases that billing staff have time to prioritize manually.

Start 3 Free Prior Authorization Appeals

Frequently Asked Questions

What happens if prior authorization is denied?

When prior authorization is denied, you receive a written notice specifying the reason, your appeal rights, and the deadline to file. The most effective immediate response is to request peer-to-peer review — a direct call between the ordering physician and the insurer's medical director — before filing a formal written appeal. P2P overturns more than 50% of denials at major payers and can resolve the case within 24–72 hours without consuming formal appeal resources or triggering the longer written review process.

How long do I have to appeal a prior authorization denial?

Deadlines vary by payer and plan type. UHC gives 65 days from denial; Aetna, BCBS, and Cigna give 180 days; Medicare Advantage plans give 60 days. These are the formal appeal filing deadlines. P2P request windows are significantly shorter — 7 days at Cigna EviCore, 14 days at UHC and Humana, 30 days at Aetna — and must be acted on before the formal appeal is filed. For a complete breakdown of deadlines across all major payers, see the insurance appeal deadlines guide 2026.

Does requesting peer-to-peer review count as a formal appeal?

No. Peer-to-peer review is a separate, informal intervention that does not consume your formal appeal rights. If P2P fails, you can still file a Level 1 formal appeal within the original deadline. The sequence risk runs in the other direction: at some payers, filing a formal appeal before requesting P2P closes the P2P scheduling queue for that denial. Use P2P first.

What is the success rate for each level of prior authorization appeal?

Published data shows Level 1 formal internal appeals achieving approximately 82% partial or full overturn in Medicare Advantage plans (HHS data, 2019–2023). Peer-to-peer review overturns more than 50% of denials across specialties, with higher rates in imaging and oncology. External independent review (IRO) overturns approximately 40% of cases that reach it. Each level sees a lower overturn rate because the strongest clinical cases resolve at earlier steps.

Can I request expedited review if the PA denial involves urgent care?

Yes. If standard timelines would "seriously jeopardize life, health, or the ability to regain maximum function," you can request expedited review at any level. Under CMS-0057-F (effective January 1, 2026), expedited initial PA decisions must be issued within 72 hours for plans subject to the rule. When requesting expedited status, quote the phrase "seriously jeopardize life or health" verbatim — CMS has documented that paraphrased urgency language is routinely downgraded to standard review by payer intake teams.

What if my formal appeal is denied?

After a Level 1 internal appeal denial, you have the right to external independent review by an IRO — board-certified physicians not affiliated with the insurer. The IRO's decision is binding on the payer. The request instructions are included in your Level 1 denial letter; the deadline to request is typically 4 months from the denial date. External review is free by federal law. For Medicare Advantage, the IRE review is followed by ALJ hearing rights if the IRE also denies. For a full walkthrough, see the independent review organization appeal guide 2026.

Should the billing team or the physician handle the peer-to-peer review call?

The ordering or treating physician must initiate and conduct the peer-to-peer call — most payers will not schedule with billing staff acting alone. Billing teams can handle the logistics: calling the scheduling line, selecting the time slot, and preparing a clinical brief organized around the payer's specific coverage criteria and the cited denial reason. Physicians who go into P2P calls with a one-page brief that directly addresses the denial's cited deficiency consistently outperform those who summarize clinical history ad hoc.

What is the difference between internal and external prior authorization appeals?

An internal appeal is submitted to the insurance company itself, where their medical director or appeals department reviews your case. Internal appeals must be completed before external review becomes available. External review (also called independent review) is conducted by an IRO — physicians with no affiliation to the insurer. External review is free, legally binding on the insurer, and available only after internal appeals are exhausted or the payer fails to follow proper procedures. For ERISA self-funded plans, external review is voluntary; for fully insured commercial and Medicare Advantage plans, it is mandatory.

---

Ready to Stop Missing the P2P Window?

Most practices learn about the peer-to-peer review window after it has already closed. The 5-step sequence above captures the fastest intervention first — P2P scheduling from denial receipt — and preserves the formal appeal and external review options for the denials that P2P does not resolve.

Muni Appeals handles:

• P2P request tracking from denial date, per payer window
• Level 1 formal appeal built against the payer's cited policy criteria
• Deadline tracking across all active cases simultaneously
• All major payers: Aetna, BCBS, UHC, Cigna, Humana, Medicare Advantage, EviCore

Start 3 Free Prior Authorization Appeals

---

This guide reflects 2026 prior authorization and appeal procedures, including CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) requirements effective January 1, 2026. CMS-0057-F applies to Medicare Advantage organizations, Medicaid managed care plans, and ACA marketplace QHPs — not to commercial self-funded ERISA plans. Appeal deadlines and timelines vary by insurance company, plan type, and state. This information is for administrative guidance and is not medical or legal advice.